Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals

Clinical Therapeutics

Volumn 28, Issue 12, 2006, Pages 2105-2118

  David Bradford, W ^a   Kleit, Andrew N ^b   Nietert, Paul J ^a   Ornstein, Steven ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

direct to consumer advertising; LDL C; statin; treatment

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONSUMER; DRUG MARKETING; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RECORD; MEDICAL SOCIETY; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; RISK ASSESSMENT;

ADVERTISING; AGED; CHOLESTEROL, LDL; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MEDICAL RECORDS; MIDDLE AGED; TELEVISION; TREATMENT OUTCOME;

EID: 33846864622     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2006.12.015     Document Type: Article

References (20)

1. Herskovits B. Both sides of DTC debate rally while FDA holds panels. PR Week (November 7, 2005)
2. Gonul F.F., Carter F., and Wind J. What kind of patients and physicians value direct-to-consumer advertising of prescription drugs?. Health Care Manag Sci. 3 (2000) 215-226
3. Sumpradit N., Fors S.W., and McCormick L. Consumers' attitudes and behavior toward prescription drug advertising. Am J Health Behav. 26 (2002) 68-75
4. Zachry III W.M., Dalen J.E., and Jackson T.R. Clinicians' responses to direct-to-consumer advertising of prescription medications. Arch Intern Med. 163 (2003) 1808-1812
5. Suppl Web Exclusives:W4-219-W4-233. Weissman J.S., Blumenthal D., Silk A.J., et al. Physicians report on patient encounters involving direct-to-consumer advertising. Health Aff (Millwood) (2004)
6. February 26, 2003. Available at:. Weissman J., et al. Consumer reports on the health effects of direct to consumer advertising, Health Affairs Web Exclusive. Accessed January 5, 2006 (2003). http://www.content.healthaffairs.org/cgi/reprint/hlthaff.w3.82vl?
7. Bell R.A., Wilkes M.S., and Kravitz R.L. The educational value of consumer-targeted prescription drug print advertising. J Fam Pract. 49 (2000) 1092-1098
8. [published correction appears in JAMA. 2005;294:2436]. Kravitz R.L., Epstein R.M., Feldman M.D., et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: A randomized controlled trial. JAMA 293 (2005) 1995-2002
9. Calfee J., Winston C., and Stempski R. Direct-to-consumer advertising and the demand for cholesterol reducing drugs. J Law Econ. 45 (2002) 673-690
10. Zachry III W.M., Shepherd M.D., Hinich M.J., et al. Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. Am J Health Syst Pharm. 59 (2002) 42-49
11. Donohue J.M., Berndt E.R., Rosenthal M., et al. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care. 42 (2004) 1176-1185
12. Wosinska M. Direct-to-consumer advertising and drug therapy compliance. J Market Res. 42 (2005) 323-332
13. Bradford W.D., Kleit A.N., Nietert P.J., et al. How direct-toconsumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior. Health Aff (Millwood) 25 (2006) 1371-1377
14. Washington, DC. Bradford W.D., et al. The effect of direct to consumer television advertising on the timing of treatment. Accessed November 15, 2006. AEI-Brookings Papers, 2005(05-19) (2005). http://www.aeibrookings.org/publications/abstract.php?pid=990 Accessed November 15, 2006
15. Rubin P. Economics of prescription drug advertising. J Res Pharm Econ. 3 (1991) 29-39
16. Rubin P.H., and Schrag J.L. Mitigating agency problems by advertising, with special reference to managed health care. South Econ J. 66 (1999) 39-60
17. Keith A. Regulating information about aspirin and the prevention of heart attack. Am Econ Rev. 85 (1995) 96-99
18. Masson A., and Rubin P.H. Matching prescription drugs and consumers. The benefits of direct advertising. N Engl J Med. 313 (1985) 513-515
19. Practice Partner Research Network (PPRNet) [PPRNet Web site] (2006). http://www.musc.edu/PPRNET/
20. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (AdultTreatment Panel III) (2001), National Institutes of Health, National Heart, Lung, and Blood Institute, Washington, DC